Nifty

:

20855.10

Sensex

:

69296.14

168.30 (0.81%)
431.02 (0.63%)

Login

Nifty
Sensex

:
:

20855.10
69296.14

168.30 (0.81%)
431.02 (0.63%)

Lyka Labs Ltd.

Pharmaceuticals & Drugs

Rating :

40/99

BSE: 500259 | NSE: LYKALABS

Watchlist

NSE BSE

121.15

05-Dec-2023

Open
High
Low
Previous Close

125.10
128.00
120.50
125.75

Volume
Traded Value (lacs)
52 Week High
52 Week Low

68981
84.55
155.90
88.50

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

401.05
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

448.44
N/A
6.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
5.63
2.57

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
76.53
-3.07

PAT CAGR (%)

10 Years
5 Years
3 Years

-
18.94
4.58

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

4.35
4.73
13.99

EV:EBITDA (Average)

8 Years
5 Years
3 Years

98.27
159.76
13.81

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 26.76 22.13 20.92% 21.24 21.88 -2.93% 19.46 27.68 -29.70% 17.13 28.18 -39.21%
Expenses 22.82 17.40 31.15% 18.68 15.96 17.04% 16.72 16.12 3.72% 14.91 16.26 -8.30%
EBITDA 3.94 4.73 -16.70% 2.56 5.92 -56.76% 2.73 11.56 -76.38% 2.22 11.92 -81.38%
EBIDTM 14.71% 21.38% 12.04% 27.06% 14.04% 41.77% 12.95% 42.31%
Other Income 0.30 1.04 -71.15% 0.43 0.68 -36.76% 0.62 0.66 -6.06% 1.11 0.67 65.67%
Interest 1.17 2.91 -59.79% 1.33 2.80 -52.50% 2.81 2.91 -3.44% 3.04 4.60 -33.91%
Depreciation 3.46 3.45 0.29% 3.34 3.41 -2.05% 3.32 9.13 -63.64% 3.33 2.12 57.08%
PBT -0.44 -0.74 - -1.68 0.39 - -2.93 -2.62 - -9.93 6.06 -
Tax -0.15 -0.34 - 0.04 0.06 -33.33% 0.08 12.61 -99.37% 0.28 0.38 -26.32%
PAT -0.29 -0.40 - -1.72 0.33 - -3.00 -15.23 - -10.21 5.68 -
PATM -1.09% -1.79% -8.10% 1.49% -15.44% -55.03% -59.62% 20.15%
EPS -0.09 -0.12 - -0.52 0.10 - -0.91 -4.60 - -3.09 1.72 -

Description Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var%
Net Sales 27.99 25.53 9.64% 22.88 27.49 -16.77% 22.24 35.19 -36.80% 17.82 35.57 -49.90%
Expenses 23.81 20.50 16.15% 20.23 21.19 -4.53% 18.94 22.58 -16.12% 15.60 22.55 -30.82%
EBITDA 4.18 5.03 -16.90% 2.64 6.30 -58.10% 3.30 12.60 -73.81% 2.21 13.02 -83.03%
EBIDTM 14.94% 19.70% 11.56% 22.92% 14.82% 35.82% 12.42% 36.60%
Other Income 0.25 1.19 -78.99% 0.38 0.72 -47.22% 0.43 0.53 -18.87% 1.06 0.41 158.54%
Interest 1.19 3.03 -60.73% 1.35 2.91 -53.61% 2.85 2.99 -4.68% 3.08 4.64 -33.62%
Depreciation 3.60 3.62 -0.55% 3.47 3.59 -3.34% 3.47 9.46 -63.32% 3.47 2.24 54.91%
PBT -0.79 -0.64 - -1.80 0.76 - -3.00 -2.11 - -10.29 6.72 -
Tax -0.18 -0.30 - 0.13 0.05 160.00% 0.00 12.88 -100.00% 0.23 0.44 -47.73%
PAT -0.62 -0.34 - -1.93 0.71 - -3.00 -14.99 - -10.52 6.28 -
PATM -2.20% -1.34% -8.44% 2.58% -13.47% -42.60% -59.06% 17.65%
EPS -0.15 -0.13 - -0.56 0.21 - -0.98 -5.25 - -3.63 2.12 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Net Sales 84.59 80.59 164.35 62.26 40.74 41.18 41.68 78.01 57.27 90.48 86.80 Net Sales Growth -15.30% -50.96% 163.97% 52.82% -1.07% -1.20% -46.57% 36.21% -36.70% 4.24% Cost Of Goods Sold 32.09 29.06 30.87 23.52 21.02 22.24 21.53 36.31 34.22 50.81 54.39 Gross Profit 52.50 51.53 133.49 38.74 19.73 18.94 20.15 41.70 23.06 39.67 32.41 GP Margin 62.07% 63.94% 81.22% 62.22% 48.43% 45.99% 48.34% 53.45% 40.27% 43.84% 37.34% Total Expenditure 73.13 64.99 66.85 47.84 43.96 40.27 42.20 56.24 49.67 70.87 87.13 Power & Fuel Cost - 3.57 3.88 2.91 2.52 2.22 1.80 1.84 1.32 1.99 3.07 % Of Sales - 4.43% 2.36% 4.67% 6.19% 5.39% 4.32% 2.36% 2.30% 2.20% 3.54% Employee Cost - 17.48 16.22 13.03 11.71 9.99 10.90 9.99 6.58 9.64 13.99 % Of Sales - 21.69% 9.87% 20.93% 28.74% 24.26% 26.15% 12.81% 11.49% 10.65% 16.12% Manufacturing Exp. - 5.04 4.13 2.89 1.70 1.27 1.06 1.20 0.80 1.39 1.22 % Of Sales - 6.25% 2.51% 4.64% 4.17% 3.08% 2.54% 1.54% 1.40% 1.54% 1.41% General & Admin Exp. - 7.11 5.62 3.78 4.30 3.86 3.40 2.76 2.40 2.61 4.32 % Of Sales - 8.82% 3.42% 6.07% 10.55% 9.37% 8.16% 3.54% 4.19% 2.88% 4.98% Selling & Distn. Exp. - 1.84 4.54 1.23 0.84 0.07 0.15 0.36 0.47 0.86 2.93 % Of Sales - 2.28% 2.76% 1.98% 2.06% 0.17% 0.36% 0.46% 0.82% 0.95% 3.38% Miscellaneous Exp. - 0.89 1.60 0.48 1.88 0.61 3.35 3.77 3.89 3.56 2.93 % Of Sales - 1.10% 0.97% 0.77% 4.61% 1.48% 8.04% 4.83% 6.79% 3.93% 8.31% EBITDA 11.45 15.60 97.50 14.42 -3.22 0.91 -0.52 21.77 7.60 19.61 -0.33 EBITDA Margin 13.54% 19.36% 59.32% 23.16% -7.90% 2.21% -1.25% 27.91% 13.27% 21.67% -0.38% Other Income 2.46 3.45 2.72 2.21 2.60 2.66 1.89 1.71 11.93 1.71 4.60 Interest 8.35 11.57 19.92 25.55 19.01 5.73 7.76 16.54 12.68 19.76 25.48 Depreciation 13.45 13.52 15.39 8.05 7.77 4.44 6.31 5.53 2.64 3.83 5.43 PBT -14.98 -6.03 64.91 -16.97 -27.40 -6.59 -12.69 1.41 4.22 -2.27 -26.64 Tax 0.25 0.08 20.34 -3.94 0.24 -8.83 -0.38 -0.37 0.00 0.00 0.00 Tax Rate -1.67% -0.61% 33.76% 21.41% -0.44% 124.37% 3.39% 67.27% 0.00% 0.00% 0.00% PAT -15.22 -13.29 39.90 -14.46 -55.39 1.73 -10.84 -0.19 4.82 1.37 -7.27 PAT before Minority Interest -15.22 -13.29 39.90 -14.46 -55.39 1.73 -10.84 -0.19 4.82 1.37 -7.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -17.99% -16.49% 24.28% -23.23% -135.96% 4.20% -26.01% -0.24% 8.42% 1.51% -8.38% PAT Growth 0.00% - - - - - - - 251.82% - EPS -4.60 -4.02 12.05 -4.37 -16.73 0.52 -3.27 -0.06 1.46 0.41 -2.20

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Net Sales 90.93 93.07 194.08 86.25 61.49 70.78 59.81 110.08 130.41 166.27 118.86 Net Sales Growth -26.54% -52.05% 125.02% 40.27% -13.13% 18.34% -45.67% -15.59% -21.57% 39.89% Cost Of Goods Sold 35.14 37.55 52.97 37.97 35.79 39.25 29.38 53.85 70.43 90.74 64.14 Gross Profit 55.79 55.52 141.11 48.28 25.70 31.54 30.43 56.23 59.98 75.53 54.72 GP Margin 61.36% 59.65% 72.71% 55.98% 41.80% 44.56% 50.88% 51.08% 45.99% 45.43% 46.04% Total Expenditure 78.58 76.23 92.94 66.57 65.16 72.68 63.36 87.31 110.25 137.62 110.32 Power & Fuel Cost - 3.60 3.92 2.94 2.56 2.28 1.86 1.90 1.39 2.06 3.11 % Of Sales - 3.87% 2.02% 3.41% 4.16% 3.22% 3.11% 1.73% 1.07% 1.24% 2.62% Employee Cost - 18.61 18.06 14.57 13.86 14.69 16.98 17.24 14.71 17.26 16.39 % Of Sales - 20.00% 9.31% 16.89% 22.54% 20.75% 28.39% 15.66% 11.28% 10.38% 13.79% Manufacturing Exp. - 5.09 4.20 3.00 1.73 1.32 1.06 1.20 1.24 1.93 1.46 % Of Sales - 5.47% 2.16% 3.48% 2.81% 1.86% 1.77% 1.09% 0.95% 1.16% 1.23% General & Admin Exp. - 7.89 6.29 4.31 5.70 5.91 5.81 5.96 6.62 7.42 5.90 % Of Sales - 8.48% 3.24% 5.00% 9.27% 8.35% 9.71% 5.41% 5.08% 4.46% 4.96% Selling & Distn. Exp. - 2.59 5.75 2.65 2.27 5.17 2.95 0.37 8.61 13.20 11.03 % Of Sales - 2.78% 2.96% 3.07% 3.69% 7.30% 4.93% 0.34% 6.60% 7.94% 9.28% Miscellaneous Exp. - 0.90 1.74 1.14 3.24 4.07 5.31 6.80 7.25 5.00 11.03 % Of Sales - 0.97% 0.90% 1.32% 5.27% 5.75% 8.88% 6.18% 5.56% 3.01% 6.97% EBITDA 12.33 16.84 101.14 19.68 -3.67 -1.90 -3.55 22.77 20.16 28.65 8.54 EBITDA Margin 13.56% 18.09% 52.11% 22.82% -5.97% -2.68% -5.94% 20.68% 15.46% 17.23% 7.18% Other Income 2.12 3.40 2.09 1.56 3.09 2.09 2.13 2.24 2.06 2.35 5.37 Interest 8.47 11.87 20.13 25.94 20.07 7.17 9.58 18.72 16.42 25.57 28.53 Depreciation 14.01 14.15 17.35 8.32 8.01 7.31 11.28 10.25 9.32 10.87 8.80 PBT -15.88 -5.78 65.77 -13.02 -28.66 -14.29 -22.28 -3.97 -3.52 -5.44 -23.43 Tax 0.18 -0.02 20.80 -4.05 0.74 -9.07 -1.04 -1.51 -0.19 1.06 1.25 Tax Rate -1.13% 0.15% 35.11% 28.62% -1.20% 58.78% 5.19% 18.62% -4.86% -28.96% -30.79% PAT -16.07 -13.21 39.00 -11.55 -60.54 -5.55 -17.21 -5.54 3.69 -4.95 -6.59 PAT before Minority Interest -15.76 -13.15 38.44 -10.09 -62.62 -6.35 -19.00 -6.60 4.09 -4.72 -5.30 Minority Interest 0.31 -0.06 0.56 -1.46 2.08 0.80 1.79 1.06 -0.40 -0.23 -1.29 PAT Margin -17.67% -14.19% 20.09% -13.39% -98.46% -7.84% -28.77% -5.03% 2.83% -2.98% -5.54% PAT Growth 0.00% - - - - - - - - - EPS -4.85 -3.99 11.78 -3.49 -18.29 -1.68 -5.20 -1.67 1.11 -1.50 -1.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Shareholder's Funds 76.43 44.44 4.41 18.78 98.60 96.78 73.61 66.50 61.16 62.75 Share Capital 30.69 28.69 28.69 28.69 28.14 28.14 22.04 23.13 22.67 22.67 Total Reserves 28.30 15.75 -24.28 -9.91 69.71 67.89 51.57 43.38 38.18 40.08 Non-Current Liabilities 72.46 70.40 147.35 134.87 71.56 6.17 36.77 27.48 32.27 58.07 Secured Loans 0.00 0.00 150.35 125.05 77.90 3.84 34.64 25.27 28.73 46.97 Unsecured Loans 63.40 61.63 0.71 0.64 0.90 0.87 0.84 0.00 0.00 7.67 Long Term Provisions 2.13 2.44 2.68 2.83 2.77 2.54 2.20 2.07 3.05 3.11 Current Liabilities 29.97 93.68 45.39 55.34 68.29 140.46 131.37 134.04 139.68 141.71 Trade Payables 8.23 8.68 12.02 16.50 22.10 21.34 28.11 30.24 39.41 34.65 Other Current Liabilities 12.93 64.08 21.66 26.33 32.27 81.91 64.47 56.66 63.75 61.53 Short Term Borrowings 7.64 19.90 10.09 10.59 12.41 35.59 37.67 46.24 36.07 45.06 Short Term Provisions 1.17 1.02 1.62 1.91 1.51 1.62 1.13 0.90 0.45 0.47 Total Liabilities 178.86 208.52 197.15 208.99 238.45 243.41 241.75 228.02 233.11 262.53 Net Block 65.53 90.11 95.34 101.65 76.23 81.16 86.27 60.26 61.67 93.83 Gross Block 153.59 171.88 162.94 140.52 93.40 94.27 92.84 99.84 98.29 132.94 Accumulated Depreciation 88.07 81.76 67.60 38.87 17.17 13.11 6.58 39.58 36.63 39.11 Non Current Assets 136.56 161.32 171.41 178.29 189.43 190.17 193.96 169.30 169.28 195.54 Capital Work in Progress 16.23 17.74 24.40 26.40 29.71 26.43 24.23 30.17 27.03 21.78 Non Current Investment 32.40 32.40 32.40 32.40 62.45 62.45 62.45 62.57 62.57 62.53 Long Term Loans & Adv. 22.41 21.06 19.28 17.83 21.03 20.12 21.01 16.30 18.02 17.40 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 42.30 47.19 25.73 30.70 49.03 53.24 47.79 58.73 63.84 66.98 Current Investments 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 Inventories 6.94 8.18 4.30 5.71 5.95 7.30 9.25 6.96 12.56 8.60 Sundry Debtors 17.16 17.59 9.90 6.59 29.68 30.26 24.22 26.45 28.83 25.36 Cash & Bank 8.70 15.38 6.53 8.40 0.09 0.47 1.46 1.73 1.70 6.51 Other Current Assets 9.49 2.21 2.42 4.22 13.31 15.22 12.86 23.59 20.74 26.51 Short Term Loans & Adv. 7.17 3.82 2.58 5.77 6.62 14.91 11.29 19.92 17.46 23.27 Net Current Assets 12.33 -46.48 -19.66 -24.64 -19.26 -87.22 -83.57 -75.31 -75.84 -74.73 Total Assets 178.86 208.51 197.14 208.99 238.46 243.41 241.75 228.03 233.12 262.52

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Shareholder's Funds 45.44 13.34 -25.80 -14.34 43.02 49.47 37.71 45.24 43.06 52.71 Share Capital 30.69 28.69 28.69 28.69 28.14 28.14 22.04 23.13 22.67 22.67 Total Reserves -2.69 -15.35 -54.49 -43.03 14.12 20.57 15.67 22.11 20.07 30.05 Non-Current Liabilities 73.25 72.77 148.88 136.67 72.28 5.28 38.68 28.52 36.95 65.16 Secured Loans 0.39 0.86 150.65 125.45 78.39 4.06 34.93 25.31 28.92 50.33 Unsecured Loans 63.40 61.63 0.71 0.64 0.90 0.87 0.84 0.00 0.00 7.67 Long Term Provisions 2.44 3.47 3.66 3.86 4.08 3.63 4.39 2.92 4.30 4.20 Current Liabilities 32.60 99.35 49.88 66.32 84.81 167.12 165.45 162.83 195.24 208.09 Trade Payables 9.41 12.00 14.71 18.85 23.23 24.21 39.16 42.08 54.64 63.26 Other Current Liabilities 14.35 66.24 23.10 30.83 43.31 92.38 73.07 56.55 79.41 77.72 Short Term Borrowings 7.64 20.07 10.37 14.41 16.26 45.82 50.23 59.95 59.85 66.20 Short Term Provisions 1.20 1.05 1.70 2.23 2.02 4.72 2.99 4.26 1.35 0.91 Total Liabilities 151.52 185.61 173.66 187.88 202.85 225.23 248.87 240.50 278.76 329.26 Net Block 68.10 93.96 98.19 104.78 107.73 116.04 132.90 104.23 121.64 162.45 Gross Block 157.96 177.35 202.50 188.36 202.81 155.31 144.01 200.41 213.51 248.18 Accumulated Depreciation 89.87 83.40 104.31 83.58 95.08 39.27 11.11 96.18 91.87 85.73 Non Current Assets 107.32 133.42 144.59 152.00 167.75 176.16 186.07 158.70 177.08 211.17 Capital Work in Progress 16.23 17.74 25.76 27.76 31.07 27.88 24.23 30.17 27.03 21.78 Non Current Investment 0.04 0.01 0.01 0.01 0.01 0.23 0.26 0.39 0.32 0.30 Long Term Loans & Adv. 22.96 21.71 20.63 19.46 28.94 32.01 28.69 23.92 28.09 26.65 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 44.20 52.20 29.08 35.88 35.11 49.07 62.79 81.81 101.69 118.09 Current Investments 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 Inventories 6.95 8.20 4.31 6.73 7.00 11.20 13.24 10.81 19.25 15.83 Sundry Debtors 20.13 18.45 8.67 8.04 14.63 20.50 29.17 43.29 56.70 68.02 Cash & Bank 11.71 17.05 7.15 10.30 1.71 2.43 5.12 5.56 6.51 10.71 Other Current Assets 5.41 2.87 4.73 6.54 11.77 14.95 15.25 22.14 19.23 23.54 Short Term Loans & Adv. 2.48 5.62 4.21 4.26 9.64 13.21 10.92 17.22 14.57 18.24 Net Current Assets 11.61 -47.15 -20.80 -30.44 -49.70 -118.05 -102.66 -81.03 -93.55 -90.00 Total Assets 151.52 185.62 173.67 187.88 202.86 225.23 248.86 240.51 278.77 329.26

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Cash From Operating Activity 6.87 76.53 5.75 -11.45 18.31 6.84 20.17 7.70 29.08 55.37 PBT -13.21 60.24 -18.40 -55.15 -7.10 -11.22 -0.56 4.82 1.37 -7.27 Adjustment 31.31 37.60 33.97 54.79 10.34 11.81 22.16 3.29 17.53 27.22 Changes in Working Capital -10.81 -20.76 -9.10 -11.85 15.30 6.69 -0.29 -0.22 10.28 76.67 Cash after chg. in Working capital 7.29 77.08 6.47 -12.22 18.53 7.28 21.31 7.89 29.17 96.61 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.41 -0.55 -0.72 0.77 -0.22 -0.44 -1.20 -0.07 -0.83 -0.36 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.06 -0.11 0.74 -40.88 Cash From Investing Activity 6.77 -4.33 0.13 0.13 -2.94 -3.35 -5.25 5.46 28.74 -24.54 Net Fixed Assets 19.80 -2.28 -20.42 -43.81 -2.41 -3.63 12.94 -4.69 29.40 -9.46 Net Investments 0.00 0.00 0.00 30.05 -0.01 0.00 0.12 0.00 -0.04 -42.31 Others -13.03 -2.05 20.55 13.89 -0.52 0.28 -18.31 10.15 -0.62 27.23 Cash from Financing Activity -20.33 -63.35 -7.75 19.61 -15.76 -4.48 -15.20 -13.13 -62.62 -28.88 Net Cash Inflow / Outflow -6.69 8.85 -1.88 8.28 -0.38 -0.99 -0.28 0.03 -4.81 1.95 Opening Cash & Equivalents 15.38 6.53 8.40 0.12 0.47 1.46 1.73 1.70 6.51 4.56 Closing Cash & Equivalent 8.70 15.38 6.53 8.40 0.09 0.47 1.46 1.73 1.70 6.51

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Cash From Operating Activity 8.95 79.25 8.81 5.32 26.67 10.88 31.38 11.95 26.54 89.10 PBT -13.17 59.25 -14.14 -61.88 -15.42 -20.04 -8.10 3.69 -4.95 -6.59 Adjustment 31.78 41.93 35.40 55.76 15.17 20.79 30.53 16.15 31.64 32.87 Changes in Working Capital -9.86 -21.01 -11.64 10.94 27.65 10.36 10.10 -7.57 -0.79 66.90 Cash after chg. in Working capital 8.75 80.16 9.62 4.82 27.39 11.10 32.53 12.27 25.90 93.17 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.20 -0.92 -0.81 0.50 -1.10 -0.44 -1.20 -0.33 -0.10 1.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.37 0.23 0.06 0.00 0.74 -5.10 Cash From Investing Activity 7.35 -6.17 -0.16 -0.11 -3.97 -3.17 -12.67 17.29 28.99 -56.87 Net Fixed Assets 19.80 -2.28 -20.42 -43.81 -2.41 -3.63 12.94 -4.69 29.40 -9.46 Net Investments 0.00 0.00 0.00 30.05 -0.01 0.00 0.12 0.00 -0.04 -42.31 Others -12.45 -3.89 20.26 13.65 -1.55 0.46 -25.73 21.98 -0.37 -5.10 Cash from Financing Activity -21.64 -63.18 -11.80 3.38 -23.42 -10.41 -19.15 -30.19 -59.72 -26.32 Net Cash Inflow / Outflow -5.34 9.90 -3.15 8.60 -0.72 -2.69 -0.43 -0.96 -4.20 5.91 Opening Cash & Equivalents 17.05 7.15 10.30 1.71 2.43 5.12 5.56 6.51 10.71 4.80 Closing Cash & Equivalent 11.71 17.05 7.15 10.30 1.70 2.43 5.12 5.56 6.51 10.71

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Book Value (Rs.) 19.22 15.49 1.54 6.55 34.77 34.12 33.40 28.49 26.27 26.86 ROA -6.86% 19.67% -7.12% -24.76% 0.72% -4.47% -0.08% 2.09% 0.55% -2.85% ROE -25.69% 163.37% -124.71% -94.98% 1.79% -12.78% -0.27% 8.07% 2.38% -11.80% ROCE -1.02% 47.25% 4.45% -20.89% -0.70% -1.80% 9.01% 10.47% 11.62% 9.28% Fixed Asset Turnover 0.50 0.98 0.41 0.35 0.44 0.45 0.88 0.61 0.83 0.71 Receivable days 78.69 30.52 48.35 162.49 265.62 233.98 108.50 166.05 102.46 164.50 Inventory Days 34.25 13.86 29.33 52.19 58.69 71.09 34.72 58.64 40.00 44.98 Payable days 106.20 122.42 221.30 152.63 195.00 214.53 192.84 278.75 197.37 169.02 Cash Conversion Cycle 6.74 -78.04 -143.63 62.05 129.31 90.54 -49.62 -54.06 -54.91 40.46 Total Debt/Equity 1.21 2.90 36.68 7.29 0.94 1.06 1.53 1.64 1.86 2.35 Interest Cover -0.14 4.02 0.28 -1.90 -0.24 -0.45 0.97 1.38 1.07 0.71

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Jun 15 Jun 14
Book Value (Rs.) 9.12 4.65 -8.99 -5.00 15.02 16.78 15.82 16.94 14.99 18.55 ROA -7.80% 21.40% -5.58% -32.05% -2.97% -8.02% -2.70% 1.58% -1.55% -1.72% ROE -63.63% 0.00% 0.00% -448.65% -14.20% -46.30% -18.27% 11.74% -13.05% -11.06% ROCE -1.00% 56.68% 8.95% -31.39% -5.50% -6.52% 6.66% 12.41% 11.73% 11.93% Fixed Asset Turnover 0.56 1.02 0.44 0.31 0.40 0.41 0.68 0.65 0.75 0.57 Receivable days 75.65 25.51 35.37 67.29 90.56 149.54 113.31 136.29 132.10 204.83 Inventory Days 29.71 11.76 23.36 40.77 46.92 73.58 37.61 40.97 37.15 49.11 Payable days 104.00 92.01 161.35 117.58 127.84 181.43 174.53 168.94 158.77 188.04 Cash Conversion Cycle 1.36 -54.74 -102.62 -9.53 9.65 41.69 -23.60 8.32 10.48 65.90 Total Debt/Equity 2.58 9.76 -6.30 -9.85 2.28 2.39 3.60 3.12 4.05 3.97 Interest Cover -0.11 3.94 0.45 -2.08 -1.15 -1.09 0.57 1.24 0.86 0.86

Top Investors:

thermo pads private limited

Annual Reports:

News Update:

Lyka Labs - Quarterly Results
2nd Nov 2023, 13:56 PM

Read More
Lyka Labs gets product permission from CDSCO for Tofacitinib Ointment
10th Oct 2023, 12:11 PM

The company has received this permission after successfully completing the Clinical Trial on 125 patients across 8 Clinical Trial Centers within India
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback